Skip to main content
. 2012 Apr 12;8(4):e1002638. doi: 10.1371/journal.pgen.1002638

Figure 7. Magnesium sulfate administration protects against hypoxia-related axon pathfinding defects.

Figure 7

(A) C/L intensity ratios of increasing magnesium concentrations (mM). *p<0.01; ** p<0.001. Error bars SEM. (B, C) Magnesium reduces activation of the hif1α pathway, as shown by decreased igfbp-1 expression following hypoxia and concurrent magnesium exposure from 24–36 hpf. Bright-field images; ventral views, rostral top, scale bar 50 µm. (D) C/L intensity ratios shows rescue by magnesium of DMOG exposure from 24–36 hpf. *p<0.05. Error bars SEM.